Information:
Error:
ID
28451
Description
The Effects of Tirofiban in Diabetic Patients Undergoing Elective Percutaneous Coronary Intervention; ODM derived from: https://clinicaltrials.gov/show/NCT00407771
Link
https://clinicaltrials.gov/show/NCT00407771
Keywords
Versions (3)
- 1/12/18 1/12/18 -
- 1/14/18 1/14/18 -
- 1/14/18 1/14/18 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
January 14, 2018
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Coronary Artery Disease NCT00407771
Eligibility Coronary Artery Disease NCT00407771
- StudyEvent: Eligibility
Similar models
Eligibility Coronary Artery Disease NCT00407771
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Patients Diabetic | Coronary Artery Disease | Percutaneous Coronary Intervention elective
Item
diabetic patients with coronary artery disease undergoing elective percutaneous coronary intervention
boolean
C0030705 (UMLS CUI [1,1])
C0241863 (UMLS CUI [1,2])
C1956346 (UMLS CUI [2])
C1532338 (UMLS CUI [3,1])
C0439608 (UMLS CUI [3,2])
C0241863 (UMLS CUI [1,2])
C1956346 (UMLS CUI [2])
C1532338 (UMLS CUI [3,1])
C0439608 (UMLS CUI [3,2])
ST segment elevation myocardial infarction
Item
ongoing st-segment elevation myocardial infarction (mi)
boolean
C1536220 (UMLS CUI [1])
abciximab
Item
administration of abciximab during the previous two weeks
boolean
C0288672 (UMLS CUI [1])
Creatinine measurement, serum
Item
serum creatinine more than 2.5 mg/dl (221 micro-mol/l)
boolean
C0201976 (UMLS CUI [1])
Hemorrhage | Bleeding tendency
Item
ongoing bleeding or bleeding diathesis
boolean
C0019080 (UMLS CUI [1])
C1458140 (UMLS CUI [2])
C1458140 (UMLS CUI [2])
Cerebrovascular accident
Item
previous stroke in the last six months
boolean
C0038454 (UMLS CUI [1])
Major surgery
Item
major surgery within the previous six weeks
boolean
C0679637 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count <100.000 per cubic mm
boolean
C0032181 (UMLS CUI [1])
Heparin, Low-Molecular-Weight | tirofiban | eptifibatide
Item
subjects who received low-molecular-weight heparin, tirofiban, or eptifibatide within the 10 hours prior to randomization
boolean
C0019139 (UMLS CUI [1])
C0247025 (UMLS CUI [2])
C0253563 (UMLS CUI [3])
C0247025 (UMLS CUI [2])
C0253563 (UMLS CUI [3])
Oral anticoagulants | Coumarins | Exception PT-INR Level
Item
subjects on oral anticoagulation medication (coumarin derivatives) within the last 7 days unless pt-inr <1.5 times the control
boolean
C0354604 (UMLS CUI [1])
C0010207 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C1821762 (UMLS CUI [3,2])
C0441889 (UMLS CUI [3,3])
C0010207 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C1821762 (UMLS CUI [3,2])
C0441889 (UMLS CUI [3,3])